Back

Maximizing targeted medical therapy for oHCM: from trials to real world

17 May 2025 (15:15 - 15:30)
Organised by: Logo
Congress Presentation Part of: Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Iacopo Olivotto

University of Florence, Florence (Italy)

4 More presentations in this session

Presentation thumbnail
Epidemiology and unmet needs of oHCM in the general population - How common is heart failure?
Professor G. Savarese (Stockholm, SE)
Slides Video
Presentation thumbnail
Pathophysiology and rationale for CMIs in HCM and HFpEF
Professor C. Maack (Wuerzburg, DE)
Video
Presentation thumbnail
Case: challenging choice between CMIs and surgery
Doctor M. Michels (Rotterdam, NL)
Video
Presentation thumbnail
Summary
Professor I. Olivotto (Florence, IT)
Video

Access the full session

Session thumbnail
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
Video

The Event

Event poster

Heart Failure 2025

17 May 2025 15:15 CET
You may be interested in
thumbnail
Congress Session
Navigating the evolving therapeutic landscape for obstructive hypertrophic cardiomyopathy (HCM)
thumbnail
Congress Presentation
Medical therapy for hypertrophic cardiomyopathy
thumbnail
Congress Session
Optimising outcomes in patients with obstructive hypertrophic cardiomyopathy: the emerging role of cardiac myosin inhibitors

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources